,i #aahth ,,congress #ast ,session ,h4 ,r4 #fgje ,,in ,,the ,,house ,,of ,,representatives ,december #aa1 #bjbc,mr4 ,moolenaar 7for himself1 ,mrs4 ,dingell1 and ,mr4 ,correa7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review1 to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,effective ,screening and ,testing for ,tuberculosis ,act4 #b4 ,treatment of certain tests for tuberculosis as breakthrough devices ,the ,secretary of ,health and ,human ,services shall treat a device as a breakthrough device eligible for expedited development and priority review under section #eae;,b of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;e-#c7 if it is a new and innovative donor screening test with heightened sensitivity to effectively screen human cell1 tissue1 and cellular and tissue-based product donors for evidence of active or latent tuberculosis infection4 #c4 ,requiring certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis 7a7 ,in general ,the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall promulgate regulations revising part #abga of title #ba1 ,code of ,federal ,regulations1 including sections #abga4ge and #abga4he1 and any other applicable regulations1 to require-- 7#a7 an establishment that performs donor screening to screen for active and latent tuberculosis2 and 7#b7 an establishment that performs donor testing to test for active and latent tuberculosis4 7b7 ,regulations ,the ,secretary of ,health and ,human ,services shall-- 7#a7 not later than #a year after the date of enactment of this ,act1 propose the regulations required by subsection 7a72 7#b7 not later than #c months after the close of the comment period for such proposed regulations1 promulgate such regulations as final2 and 7#c7 not later than #f months after the date such regulations are promulgated as final1 begin implementation of such regulations4 7c7 ,definitions ,in this section1 the terms establishment that performs donor screening and establishment that performs donor testing have the meanings given to such terms under part #abga of title #ba1 ,code of ,federal ,regulations4 #d4 ,guidance on current good tissue practice and additional requirements for manufacturers of human cells1 tissues1 and cellular and tissue-based products ,not later than #f months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 and in coordination with the ,director of the ,centers for ,disease ,control and ,prevention1 shall-- 7#a7 review the guidance titled ,guidance for ,industry--,current ,good ,tissue ,practice 7,,cgtp7 and ,additional ,requirements for ,manufacturers of ,human ,cells1 ,tissues1 and ,cellular and ,tissue-,based ,products 7,,hct_/,ps7 7,december #bjaa72 and 7#b7 issue an updated version of such guidance4 #e4 ,compliance with ,,cutgo ,no additional funds are authorized to be appropriated to carry out this ,act1 and this ,act shall be carried out using amounts otherwise available for such purpose4